# Aveir DR i2i Study

> **NCT05252702** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 464 (actual)

## Conditions studied

- Cardiac Pacemaker, Artificial
- Cardiac Rhythm Disorder
- Bradycardia

## Interventions

- **DEVICE:** Aveir DR Leadless Pacemaker System

## Key facts

- **NCT ID:** NCT05252702
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-02
- **Primary completion:** 2023-08-02
- **Final completion:** 2025-11
- **Target enrollment:** 464 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05252702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05252702, "Aveir DR i2i Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05252702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*